Harris is ‘buying down premiums to buy votes’

The Centers for Medicare and Medicaid Services (CMS) announced in September that it would be reducing certain Medicare prescription drug premiums in what experts who spoke to the Daily Caller News Foundation called a ploy to buy votes before the November election.

Enrollees in the Medicare Part D prescription drug benefit are slated to have lower average monthly premiums for their pharmaceutical drugs next year due to the Biden-Harris administration pouring billions into subsidies for insurers...